Pharmaceutical Research and Development
Research and Development (R&D)
In this section you will find information products, including market research, covering research and development (R&D) in global biotechnology and pharmaceutical industries, with insight into pipelines, productivity, strategies and profiles of companies in Europe, the UK, the US and Asia.Stay up-to-date with new products added to this category »
| Title | Publication Date | Price |
|---|---|---|
| Top 600 Medical & Scientific Research (Europe) | January 2012 | £800 |
| Endpoints-Clinical Trials in Orphan Diseases Highest Number of Terminated Trials Focused on Mulitiple Myeloma |
January 2012 | £2215 |
| Endpoints-Clinical Trials in Dermatology Inflammatory Lesions Count is the Key Determinant of Success in Acne Vulgaris Clinical Trials |
January 2012 | £2215 |
| Top 700 Medical & Scientific Research (Global) | January 2012 | £950 |
| Top 600 Medical & Scientific Research (European) | January 2012 | £800 |
| Emerging Market for Clinical Trials in Poland Cost Advantages of Nearly 30% as Compared to the US |
December 2011 | £2215 |
| Small Cells Report 2011-2016 Analysing the Business Case of Heterogeneous Networks |
November 2011 | £1699 |
| MicroRNA Market Trends 2011 |
October 2011 | £1080 |
| Medical Research in China IBISWorld Industry Report |
October 2011 | £520 |
| DNA Microarray Market Trends (Installed Base, Applications, Purchase Plans and The Impact of Next-Gen Sequencing) |
October 2011 | £2215 |
| Scientific Research & Development in the US IBISWorld Industry Report |
October 2011 | £520 |
| Innovative R&D Strategies and Models Outsourcing, Strategic Partnerships and Licensing to Improve Productivity and Contain Costs |
September 2011 | £2215 |
| Post Marketing Clinical Research Rems, The Latest Reformation Due to Post Marketing Surveillance to Enhance Patient Compliance |
September 2011 | £2215 |
| Observing Patients Online The Changing Face of Research |
September 2011 | £415 |
| Biobanks | September 2011 | £2655 |
| High Growth Test and Measurement Market Opportunity: Modular Instruments Modular Instrumentation Expand its Reach into Research & Development |
September 2011 | £1580 |
| Medical Laboratories - Bretagne & Pays De La Loire: Analysis of French Companies | August 2011 | £495 |
| Scientific Research & Development: Analysis of French Companies | August 2011 | £495 |
| Medical Laboratories - Burgundy & Franche Comté : Analysis of French Companies | August 2011 | £495 |
| Recherche développement scientifique Analyse des performances des sociétés françaises |
August 2011 | £495 |
| Pharmaceutical Research: Analysis of French Companies | August 2011 | £495 |
| Medical Laboratories: Analysis of French Companies | August 2011 | £495 |
| UK Medical Research Business Performance Analysis |
August 2011 | £350 |
| Contract Research Organization (Clinical Research): Analysis of French Companies | August 2011 | £495 |
| Recherches Pharmaceutiques Analyse des performances des sociétés françaises |
August 2011 | £495 |
| New Research into Prescribing Practices | August 2011 | £475 |
| PAREXEL's Bio/Pharma R&D Statistical Sourcebook 2011 - 2012 |
July 2011 | £270 |
| Contract Research Annual Review 2011 |
July 2011 | £395 |
| Biobanking: Technologies and Global Markets | June 2011 | £3065 |
| Clarke's Analysis of Drugs & Poisons 4th Edition |
May 2011 | £375 |
